Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Features and molecular genetic study of low-grade oncocytic tumor of the kidney.

Annals of diagnostic pathology - 1 Aug 2026

Zhao Jing, Wang Yajie, Huang Jian, Jin Xu, Cai Yanyan, Lu Yifan, Jiang Tao, Gan Wenjuan

Abstract excerpt

OBJECTIVE: To analyze the clinicopathological features of low-grade oncocytic tumor of the kidney (LOT) and to explore its cellular origin, immunohistochemical, and molecular characteristics. METHODS: A retrospective analysis was conducted on the clinicopathological features and immunophenotypes of 7 cases of LOT diagnosed at two institutions from 2022 to 2025. The immunohistochemical expression of L1 cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoma, Oxyphilic
Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Immunohistochemistry

Share to Kidney Neoplasms

Share to Mutation

Share to Neoplasm Grading

Source

Identifiers

PMID: 41996739
DOI: 10.1016/j.anndiagpath.2026.152644

Genes

L1CAM
ALK
BRAF
FH
LRP1B
MTOR
PAX8
SDHB
TFEB
XRCC1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Features and molecular genetic study of low-grade oncocytic tumor of the kidney.PMID 41996739Read ↗

Low-grade oncocytic tumor of the kidney—a clinical, pathological, and next generation sequencing-based study of 20 tumorsSemantic proximity Read ↗

Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT.Semantic proximity Read ↗

L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma.Semantic proximity Read ↗

Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations.Semantic proximity Read ↗

Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney.Semantic proximity Read ↗

Low-grade oncocytic tumor of kidney harboring TSC/MTOR mutation: clinicopathologic, immunohistochemical and molecular characteristics support a distinct entity.Semantic proximity Read ↗

Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1.Semantic proximity Read ↗

Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity.Semantic proximity Read ↗

Concordance of MTOR Pathway Mutations and the Diagnosis of Renal Low-Grade Oncocytic Tumor (LOT).Semantic proximity Read ↗

Update on classification of oncocytic neoplasms of the kidney.Semantic proximity Read ↗

Integrated clinicopathological, genomic, and immunophenotypic landscape of renal tubulocystic oncocytoma.Semantic proximity Read ↗

Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.